TMEM16A-Mediated Mucin Secretion in IL-13-Induced Nasal Epithelial Cells From Chronic Rhinosinusitis Patients

Yu Zhang1, Xiangdong Wang2, Hong Wang3

  • 1Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Abstract

Insights

Transmembrane protein 16A (TMEM16A) and mucin 5AC (MUC5AC) are elevated in chronic rhinosinusitis with nasal polyps. TMEM16A inhibition reduced MUC5AC secretion, suggesting TMEM16A’s role in airway mucus production.

Area of Science:

  • Respiratory Medicine
  • Molecular Biology
  • Immunology

Background:

  • Chronic rhinosinusitis with nasal polyps (CRSwNP) is a Th2-mediated disease characterized by mucus hypersecretion.
  • Transmembrane protein 16A (TMEM16A), a calcium-activated chloride channel (CaCC), is implicated in airway epithelial electrolyte transport and hydration, potentially influencing mucus secretion.
  • The specific role of TMEM16A in regulating mucin production and secretion in CRSwNP remains unclear.

Purpose of the Study:

  • To investigate the role of TMEM16A in mediating mucin secretion in human nasal polyp epithelial cells (HNPECs) stimulated by interleukin-13 (IL-13).

Main Methods:

  • Assessed TMEM16A and MUC5AC expression and secretion in sinonasal tissues and primary HNPECs using immunohistochemistry, Western blot, and ELISA.
  • Induced a Th2 inflammatory environment in air-liquid interface (ALI)-cultured HNPECs with IL-13.
  • Evaluated the effect of a TMEM16A inhibitor (T16Ainh-A01) on IL-13-induced responses.

Main Results:

  • TMEM16A and MUC5AC expression were significantly increased in nasal polyp tissues and HNPECs from CRSwNP patients.
  • IL-13 treatment upregulated TMEM16A and MUC5AC expression and MUC5AC secretion in HNPECs, with TMEM16A localized to MUC5AC-positive cells.
  • Inhibition of TMEM16A by T16Ainh-A01 attenuated the IL-13-induced increase in MUC5AC secretion.

Conclusions:

  • Elevated TMEM16A and MUC5AC expression in CRSwNP may be a direct consequence of Th2 cytokine activity.
  • TMEM16A plays a significant role in regulating mucin secretion in the upper airway epithelium during inflammatory conditions like CRSwNP.
  • Targeting TMEM16A could be a potential therapeutic strategy for managing excessive mucus production in CRSwNP.